Related Experiment Videos
Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo
1University College London, Institute of Urology and Nephrology, Division of Applied Physiology, 48 Riding House Street, London, W1W 7EY, UK. naflor40@hotmail.com
Current Opinion in Investigational Drugs (London, England : 2000)
|December 25, 2002
Abstract:
Pitavastatin (nisvastatin) is an HMG CoA reductase inhibitor being developed jointly by Nissan, Kowa Kogyo, Novartis and Sankyo for the potential treatment of atherosclerosis and hyperlipidemia.